Skip to main content
Glama

Openfda

by io.github.pipeworx-io

Polymarket Fill Risk

polymarket_fill_risk
Read-onlyIdempotent

Realizable-vs-theoretical edge check against live CLOB order-book depth. REQUIRES one of market (single-market mode) or event (basket/partition mode). SINGLE-MARKET: pass a market slug/URL + side (buy_yes|sell_yes|buy_no|sell_no, default buy_yes) + size_usd (default 1000 — max spend on buys, target proceeds on sells); walks the ladder and returns top_of_book, vwap_fill_price, slippage_pp, shares_filled, max_fillable_usd, and a verdict (clean|degraded|cannot_fill). BASKET: pass an event slug/URL + side (sell_yes = capture overround by selling every leg, buy_yes = capture underround; default auto from partition sum) + size_usd interpreted as settlement notional S (shares per leg; each share pays $1); returns theoretical_sum vs realizable_sum (top-of-book vs VWAP across all legs), capture_ratio, profit_usd at executed size, per-leg fill detail, thin_legs[], max_clean_notional_usd, and forced_directional_risk naming the legs most likely to strand you unhedged. USE THIS before acting on any polymarket_arbitrage SELL/BUY-EVERY-LEG signal or any polymarket_edges trade above ~$500 — theoretical overround on thin books is not capturable, and partial basket fills convert an arb into an unhedged directional position (the dominant loss mode in real arb-bot P&L).

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
sideNoSingle-market: buy_yes | sell_yes | buy_no | sell_no (default buy_yes). Basket: sell_yes | buy_yes (default auto — sell if partition sum > 1, buy if < 1).
eventNoBasket mode: event slug or full polymarket.com URL — checks every leg of the partition.
marketNoSingle-market mode: market slug or full polymarket.com URL.
size_usdNoSingle-market: USD to spend (buys) or target proceeds (sells). Basket: settlement notional — shares per leg, each paying $1 at resolution. Default 1000, clamp 10–1,000,000.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added
  2. Removed
  3. Added

TDQS

A4.4/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already provide read-only and idempotent hints. The description adds valuable behavioral context: it walks the order-book ladder, returns specific fields (top_of_book, vwap_fill_price, etc.), and mentions forced_directional_risk. No contradiction.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single dense paragraph with rich information but could be structurally improved with bullet points or clearer separation of modes. It is front-loaded with purpose.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given complexity (two modes, many return fields) and no output schema, the description adequately covers return values (top_of_book, vwap_fill_price, slippage_pp, etc.) and risks. Sufficient for an agent to understand the tool's full behavior.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, baseline 3. The description adds meaning beyond schema: explains defaults, side auto-behavior for basket, and size_usd interpretation differences between modes. Clarifies value clamp.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs a 'Realizable-vs-theoretical edge check against live CLOB order-book depth' and specifies two modes (single-market and basket), effectively distinguishing it from siblings like polymarket_arbitrage.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly tells when to use this tool ('before acting on any polymarket_arbitrage SELL/BUY-EVERY-LEG signal or any polymarket_edges trade above ~$500') and explains risks (theoretical overrun not capturable, partial fills cause unhedged positions).

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Openfda toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation4/5

Most tools have distinct names and purposes, but the large number of meta-tools (e.g., ask_pipeworx variants, deep_research) and overlapping research/scanning tools (entity_profile, compare_entities, recent_changes) could cause confusion. An agent may need to carefully read descriptions to choose correctly.

Naming Consistency3/5

Snake_case is prevalent but not universal. FDA tools are consistently named with 'fda_' prefix, but there are single-word verbs (remember, recall), camelCase is absent, and some tool names are long and descriptive (scan_competitor_ai_presence). The mix of patterns is readable but not highly consistent.

Tool Count3/5

43 tools is high and includes both dedicated tools and meta-tools that can access thousands more. There is redundancy (e.g., FDA data can be retrieved via fda_drug_approvals or ask_pipeworx). The scope is broad, but many tools could be consolidated. Count feels borderline excessive for the apparent purpose.

Completeness4/5

FDA coverage is excellent with tools for approvals, labels, events, recalls, shortages, warning letters, etc. Other domains (financial, betting, npm) are covered by meta-tools, providing breadth. However, dedicated non-FDA tools are sparse, and the server relies heavily on the universal query tools for completeness.

Resources